Co-Authors
This is a "connection" page, showing publications co-authored by Alexander Vlaar and Frank van Baarle.
Connection Strength
0.343
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.226
-
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages. Sci Transl Med. 2021 06 02; 13(596).
Score: 0.059
-
Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study. Thromb Res. 2021 04; 200:87-90.
Score: 0.058